Triastek Awarded as 2024 Technology Pioneer by World Economic Forum


  • The World Economic Forum announces the selection of this year's 100 companies joining its Technology Pioneers.
  • Triastek, global leader in 3D printing pharmaceuticals, is selected as one of the World Economic Forum's "Technology Pioneers" for 2024.
  • This award, as recognition from The World Economic Forum, highlights Triastek's ongoing commitment to innovation and excellence.

Nanjing, China, June 6, 2024--The World Economic Forum announces today the 2024 cohort of Technology Pioneers. Triastek, global leader in 3D printing pharmaceuticals, pioneering a 3D printing pharmaceutical process to transform the delivery, development and production of medication, is selected as one of the World Economic Forum's "Technology Pioneers" for 2024. The award of Triastek reflects the authoritative recognition of its continuous innovation by the World Economic Forum.

Dr. Senping Cheng, founder and CEO of Triastek, will be invited to attend the 15th Annual Meeting of the New Champions (Summer Davos Forum) of the World Economic Forum held in Dalian from June 25 to 27, where she will share insights and seek solutions with more than 1,500 guests from the global political, business, social and international organizations on "Next Frontiers for Growth".

This year's Technology Pioneers include start-ups from 23 countries, a third led by a female chief executive. With a record number of applications, the focus this year is on companies with technology that not only made significant breakthroughs but are also now on hyper-growth trajectories.

After years of accumulating technical expertise and committing to innovation, Triastek has become a global leader in the field of 3D printed pharmaceuticals. Developing through the dual business models of "Product License-out Partnership" and "Technology Platform Partnership", Triastek has successfullly established collaboration with Eli Lilly, Merck, Boehringer Ingelheim, Siemens and Sperogenix, working with both MNCs and domestic pharmaceutical companies. Currently, Triastek has five products in the clinical stage, proving the versatility of its technology platform and reinforcing its leadership position in 3D-printed pharmaceutical pipelines.

"The 2024 Technology Pioneers are revolutionizing industries on a global scale," said Verena Kuhn, Head of Innovator Communities, World Economic Forum. "These innovators are leveraging the most advanced technologies to drive the radical changes needed to confront the world's most urgent challenges. We are excited to see how their groundbreaking work will enrich Forum initiatives and how they will contribute to building dynamic partnerships between the public and private sectors to solve these critical global issues."

"We are deeply honored to be awarded such an important award by the World Economic Forum. This is not only a recognition of Triastek's long-term commitment to innovation, but also recognizes the potential of 3D printing pharmaceuticals industry," said Dr. Senping Cheng, founder and CEO of Triastek. "In the future, we will continue to offer technical solutions to global pharmaceutical companies to enhance product development, hoping to deliver more clinically valuable and higher-quality pharmaceutical products to patients."

About Triastek

Global leader in 3D printing pharmaceuticals, Pioneer of new digital pharmaceutical processes

Founded in July 2015, Triastek is dedicated to the mission of "revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide." We have created the Melt Extrusion Deposition (MED®) 3D printing pharmaceutical process, transforming the delivery, development, and production of medicines through digital product development and continuous manufacturing.

Leveraging our proprietary 3D printing pharmaceutical technology, we design and develop transformative medicines for patients. Through collaboration with global pharmaceutical companies, we tackle challenging formulation problems, accelerating the development of new drug products and improving the quality of pharmaceuticals.

Our vision is to become the world's most influential intelligent pharmaceutical enterprise.

About the Technology Pioneers

Launched in 2000, the Technology Pioneers community is composed of early-stage companies from around the world that are involved in the design, development and deployment of new technologies and innovations and are poised to have a significant impact on business and society. The World Economic Forum provides the community with a platform to engage with public and private sector leaders and to contribute new solutions to overcome the current crisis and build future resiliency.

The Technology Pioneers community is part of the Innovator Communities within the Forum's Centre for the Fourth Industrial Revolution. The Innovator Communities convene the world's leading global start-ups across different growth stages from early-stage Technology Pioneers to growth-stage Global Innovators and unicorn companies valued at more than $1 billion.

Copyright © 2024 (TRIASTEK)

Contact Us

Follow us on


COPYRIGHT © 2024 TRIASTEK. 苏ICP备17053162号